Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Amer H. Zureikat"'
Autor:
Louisa Bolm, MD, Martina Nebbia, MD, Alice C. Wei, MD, Amer H. Zureikat, MD, Carlos Fernández-del Castillo, MD, Jian Zheng, MD, Alessandra Pulvirenti, MD, Ammar A. Javed, MD, Yurie Sekigami, MD, Natalie Petruch, Motaz Qadan, MD, PhD, Keith D. Lillemoe, MD, Jin He, MD, Cristina R. Ferrone, MD, the Pancreatic Neuroendocrine Disease Alliance (PANDA)
Publikováno v:
Annals of Surgery Open, Vol 4, Iss 2, p e277 (2023)
Externí odkaz:
https://doaj.org/article/8e6751d51c704aae9a48f609c79ae263
Autor:
Louisa Bolm, MD, Martina Nebbia, MD, Alice C. Wei, MD, Amer H. Zureikat, MD, Carlos Fernández-del Castillo, MD, Jian Zheng, MD, Alessandra Pulvirenti, MD, Ammar A. Javed, MD, Yurie Sekigami, MD, Natalie Petruch, MD, Motaz Qadan, MD, PhD, Keith D. Lillemoe, MD, Jin He, MD, Cristina R. Ferrone, MD, the PAncreatic Neuroendocrine Disease Alliance (PANDA)
Publikováno v:
Annals of Surgery Open, Vol 4, Iss 1, p e245 (2023)
Externí odkaz:
https://doaj.org/article/9a8b37a9595145f3be2cd1fe113068f9
Autor:
Samer S. AlMasri, Mazen S. Zenati, Annissa Desilva, Ibrahim Nassour, Brian A. Boone, Aatur D. Singhi, David L. Bartlett, Lance A. Liotta, Virginia Espina, Patricia Loughran, Michael T. Lotze, Alessandro Paniccia, Herbert J. Zeh III, Amer H. Zureikat, Nathan Bahary
Publikováno v:
Cancer Medicine, Vol 10, Iss 20, Pp 7233-7241 (2021)
Abstract Introduction Preoperative autophagy inhibition with hydroxychloroquine (HCQ) in combination with gemcitabine in pancreatic adenocarcinoma (PDAC) has been shown to be safe and effective in inducing a serum biomarker response and increase rese
Externí odkaz:
https://doaj.org/article/22bcc880a5264081a326a90968f1c5d6
Autor:
Naomi Fei, Sijin Wen, Rajesh Ramanathan, Melissa E. Hogg, Amer H. Zureikat, Michael T. Lotze, Nathan Bahary, Aatur D. Singhi, Herbert J. Zeh, Brian A. Boone
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 5, Pp 1822-1829 (2021)
Abstract SMAD4, a tumor suppressor gene, is lost in up to 60%–90% of pancreatic adenocarcinomas (PDAs). Loss of SMAD4 allows tumor progression by upregulating autophagy, a cell survival mechanism that counteracts apoptosis and allows intracellular
Externí odkaz:
https://doaj.org/article/fc1b523b0b3a44e2a592d00a88565d98
Autor:
Kosei Takagi, Yuzo Umeda, Ryuichi Yoshida, Takahito Yagi, Toshiyoshi Fujiwara, Amer H. Zureikat, Melissa E. Hogg, Bas Groot Koerkamp
Publikováno v:
World Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-7 (2021)
Abstract Background Growing evidence for the advantages of robotic pancreatoduodenectomy (RPD) has been demonstrated internationally. However, there has been no structured training program for RPD in Japan. Herein, we present the surgical training mo
Externí odkaz:
https://doaj.org/article/b19afc4a173245c888ad4dc12dc6ccb8
Autor:
Pranav Murthy, Aatur D. Singhi, Mark A. Ross, Patricia Loughran, Pedram Paragomi, Georgios I. Papachristou, David C. Whitcomb, Amer H. Zureikat, Michael T. Lotze, Herbert J. Zeh III, Brian A. Boone
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Background: Neutrophil extracellular traps (NETs) are generated when activated neutrophils, driven by PAD4, release their DNA, histones, HMGB1, and other intracellular granule components. NETs play a role in acute pancreatitis, worsening pancreatic i
Externí odkaz:
https://doaj.org/article/2f246b1f618e4df2a01e34b810a99c8b
Autor:
David T. Chao, Nilesh H. Shah, Herbert J. Zeh, Aatur D. Singhi, Nathan Bahary, Kevin M. McGrath, Kenneth E. Fasanella, Amer H. Zureikat, David C. Whitcomb, Randall E. Brand
Publikováno v:
Gastroenterology Research and Practice, Vol 2018 (2018)
Background. Adolescent obesity is a national epidemic that recently has been shown to increase risk for pancreatic adenocarcinoma (PC) and is associated with an earlier age of PC onset. We hypothesized that PC patients who are overweight or obese at
Externí odkaz:
https://doaj.org/article/e7071c46e6964b80ae8b5771e7bddb2c